Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Human Somatic Cells Identified by Their Locomotion Pattern.

By Labmedica staff writers
Posted on 19 Jun 2008
A novel sensor will enable human somatic cells to be identified based on their characteristic locomotion pattern. More...
The sensor is expected to facilitate the diagnosis of diseases or assessment of healing processes.

The sensor consists of a smooth surface that is studded with 250,000 tiny plastic columns measuring five microns in diameter. These columns are made of elastic polyurethane plastic. When a cell glides across them, it very slightly bends them sideways. This deflection is registered by a digital camera and analyzed by a special software program.

Manufacturing the sensor, which is called Cellforce, was complicated. The columns had to be coated in such a way that living cells were happy to move across their tips. The cells would otherwise avoid the tips and continue their journey lower down between the columns. In that case, there would be no deflection at all. The microscope required for cell magnification had to be adapted to suit the application. In order to build the delicate column structure, liquid plastic was pressed into a negative mold at a pressure of 2000 bar and allowed to harden. To allow cost-effective production of the Cellforce sensor in the future, commercially available plastics and well-established techniques from chip manufacture will be utilized.

The Cellforce sensor was devised and manufactured by scientists at the Fraunhofer Institute for Applied Optics and Precision Engineering (Institute Angewandte Optik und Feinmechanik) IOF (Jena, Germany). The project manager, Dr. Norbert Danz commented, "Analysis of cell locomotion is important for numerous applications. It could be used to check whether bone cells are successfully populating an implant, or how well a wound is healing.”

The scientists have already shown that their Cellforce sensor works. The Cellforce prototype is expected to be ready in the year 2009. It will be the task of initial biological tests to show how different cell types behave.


Related Links:
Institute for Applied Optics and Precision Engineering IOF

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.